ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Therefore, a better understanding of the biology of CML-BC is necessary to identify molecular networks that, if appropriately modulated, will simultaneously affect the function of BCR/ABL and that of multiple signals aberrantly activated in CML-BC.